Moreover, inflammatory signaling pathways, including NF-κB, JAK-STAT, and NLRP3, are aberrantly activated within the tumor microenvironment, further driving tumor cell proliferation, invasion, and the development of therapeutic resistance (6–8). Here, NFKB1 is linked to neoplasm.